The regulation of the inositol 1,4,5-trisphosphate (IP 3 ) receptor in liver was analyzed using a novel superfusion method. Hepatic microsomes were loaded with 45 Ca 2؉ , and superfused at high flow rates to provide precise control over IP 3 In many cells including hepatocytes, binding of certain hormones to cell surface receptors results in the activation of phospholipase C, thereby generating the intracellular second messenger inositol 1,4,5-trisphosphate (IP 3 ).
In many cells including hepatocytes, binding of certain hormones to cell surface receptors results in the activation of phospholipase C, thereby generating the intracellular second messenger inositol 1,4,5-trisphosphate (IP 3 ). 1 The intracellular receptor for IP 3 is a calcium channel that permits efflux of Ca 2ϩ sequestered in the endoplasmic reticulum out into the cytoplasm. Calcium diffuses through the cytoplasm, and under certain conditions, kinematic waves of elevated Ca 2ϩ concentration can be observed (1) . The amplitude of these waves is roughly constant, but the frequency of the waves correlates with extracellular receptor agonist concentration. Thus, calcium waves couple the activation of cell surface receptors to activation of calcium-dependent intracellular processes in a frequency-encoded manner (2) . The importance and complexity of changes in Ca 2ϩ concentration in transmitting information implies that calcium signaling is tightly regulated.
The IP 3 receptor occupies a central position among the multitude of molecules involved in intracellular calcium metabolism (1, 2) . It possesses regulatory properties that in principle can account for the spatio-temporal complexity of calcium signals (1, 2) . In many tissues, cytoplasmic Ca 2ϩ concentrations modulate IP 3 -dependent calcium release in a biphasic manner (3) (4) (5) (6) (7) . At submicromolar concentrations, Ca 2ϩ activates the release process, whereas, at higher concentrations, Ca 2ϩ is inhibitory. This regulation by calcium has been proposed to be a means of controlling calcium oscillations (1, 2) . The role of IP 3 in regulating the activity of its receptor is less clear. Results that support (8) as well as undermine (5, 9, 10) cooperative receptor activation have been reported. Recently, an inhibitory role for IP 3 has been proposed (11) .
The aim of this study was to characterize the regulation of the hepatic IP 3 receptor by both Ca 2ϩ and IP 3 . A superfusion assay, which was developed to study IP 3 -dependent calcium release from brain microsomes (5) , was adapted for use with liver microsomes. This assay achieves subsecond time resolution, allows for precise control of extravesicular Ca 2ϩ and IP 3 concentrations, and isolates the release of 45 Ca 2ϩ from its reuptake. We show that both extravesicular Ca 2ϩ and IP 3 can activate and inhibit the calcium channel function of the IP 3 receptor.
EXPERIMENTAL PROCEDURES
Materials-D-myo-Inositol 1,4,5-trisphosphate (hexapotassium salt) was purchased from LC Laboratories (Woburn, MA). Magnesium ATP, MOPS, dithiothreitol (DTT), EDTA, EGTA, HEPES, Percoll, phenylmethylsulfonyl fluoride, antipain, leupeptin, pepstatin, and other chemicals were obtained from Sigma. Hanks' buffer saline solution was from Life Technologies, Inc. Fura 2 was from Molecular Probes (Eugene, OR). 45 CaCl 2 was purchased from DuPont NEN. Preparation of Microsomes-A low-sedimentation low-density microsomal fraction (12) was prepared from sodium pentobarbital-anaesthetized male Sprague-Dawley rats (200 -300 g), perfused in situ with 100 ml of Hanks' buffer saline solution containing 0.5 mM EGTA, 1 mM DTT, and protease inhibitors (phenylmethylsulfonyl fluoride, 100 g/ml, leupetin, 2 g/ml, pepstatin, 1 g/ml, and antipain, 2 g/ml, pH 7.3). The tissue was minced in 40 ml of ice-cold sucrose buffer (250 mM sucrose, 5 mM HEPES, 5 mM KOH, 1 mM EDTA, 1 mM DTT, and protease inhibitors, pH adjusted with KOH to 7.4), homogenized with a glass tissue grinder (BellCo) (10 loose strokes, 10 tight strokes), and centrifuged for 10 min at 500 ϫ g. The supernatant was centrifuged for 10 min at 2,000 ϫ g and the resulting supernatant was further centrifuged for 40 min at 36,000 ϫ g to sediment the microsomes (low sedimentation). The pellet was resuspended in sucrose buffer containing 35% (v/v) Percoll and fractionated by centrifugation at 36,000 ϫ g for 30 min. The superior low density fraction was washed twice in 10 volumes of MK buffer (120 mM KCl, 20 mM MOPS, pH 7.2), with 1 mM DTT and protease inhibitors. The final pellet was resuspended at 2-5 mg/ml in MK buffer with protease inhibitors and 0.7 M glycerol, divided into 50-l portions, and stored at Ϫ70°C. 2). Loaded microsomes were then superfused as described previously (13) . Briefly, the microsomes were washed in 16 volumes of basal buffer (100 mM KCl, 20 mM MOPS, 1 mM EGTA, 5 mM MgCl 2 , free Ca 2ϩ less than 1 nM), applied to a filter support, and mounted in a superfusion chamber accessed by three solenoid-driven valves that were operated by computer. Each valve controlled the delivery of a separate pressurized solution to the chamber. Microsomes were superfused at 40 p.s.i. (flow rate ϳ 2 ml/s) for 1.05 s with basal buffer to establish a baseline rate of release. Release was evoked at t ϭ 0, by switching to a second stimulation buffer (100 mM KCl, 20 mM MOPS, 4 mM EDTA, 5 mM MgCl 2 , sufficient CaCl 2 to obtain the desired free calcium concentration, and IP 3 at the concentration specified for each experiment). The superfusate containing released 45 Ca 2ϩ was collected with a rotating fraction collector, which divided the effluent stream into 70-ms fractions. Radioactivity in each fraction and that remaining on the filter was measured by liquid scintillation counting (Beckman LS 6800) after addition of 2 ml of Biosafe II (Research Products International, Mount Prospect, IL) to each fraction. Experiments were performed in groups of 6, 3 with the desired concentrations of IP 3 and 3 with no IP 3 to control for calciumdependent release, in a randomized sequence to minimize any time-dependent changes in the preparation.
Calculations-
45
Ca 2ϩ release rates were calculated by dividing the amount of radioactivity in each fraction by the total amount remaining on the filter, expressed as % of total. In all experiments, the baseline calcium release rates were adjusted to the mean of 45 Ca 2ϩ release during the 3 fractions preceding the switch to the stimulating buffer. This adjustment was generally on the order of 5-10% of the baseline rate of release. Net IP 3 -dependent calcium release was calculated by subtracting the release rates observed in the absence of IP 3 from the rates in the presence of IP 3 for each concentration of Ca 2ϩ (5) . Cumulative IP 3 -dependent calcium release was obtained by stepwise addition of IP 3 -dependent calcium release rates. The peak rate of release was defined as the largest IP 3 -dependent 45 Ca 2ϩ release rate in a single fraction, expressed in percent per s. The initial rate of release was defined as the rate of 45 Ca 2ϩ release (expressed in percent per s) derived from the cumulative release between t ϭ 0 and the fraction with maximum rate of release.
Calcium Buffers-Free Ca 2ϩ concentrations in the loading and stimulation buffers were calculated according to Fabiato and Fabiato (14) , assuming a nominal Ca 2ϩ concentration of 3 M in distilled water. These calculations agreed with measurements of free Ca 2ϩ obtained with Fura 2 (for free Ca 2ϩ concentrations less than 1 M) or with an ion-selective electrode (for free Ca 2ϩ concentrations above 1 M).
RESULTS
The Kinetics of IP 3 (Fig. 1A) . When the stimulus buffer contained 400 nM Ca 2ϩ and 10 M IP 3 , the release event reached a maximum within two fractions (ϳ140 ms), and subsequently decayed toward a plateau rate that was significantly higher than that observed with 400 nM Ca 2ϩ alone. IP 3 -dependent release was blocked by heparin (100 g/ml) (Fig. 1B) , and was not due to calcium-dependent 45 
Ca
2ϩ release (such as that mediated by the ryanodine receptor), since superfusion with 100 M Ca 2ϩ in the absence of IP 3 produced the same amount of calcium release as did superfusion with 400 nM Ca 2ϩ alone (not shown). Nonetheless, the small amount of calcium-dependent 45 Ca 2ϩ release was subtracted from the total release rates to arrive at the net IP 3 -dependent release rates (see "Experimental Procedures"). The net IP 3 -dependent release event (Fig. 1C ) could be well described as the sum of two exponential decay phases, a fast phase that decayed with a time constant 1 ϭ 130 ms, and a slower component that decayed slowly ( 2 ϭ 0.73 s). The cumulative 45 Ca 2ϩ release event could be reconstructed by sequentially summing the release rates (Fig. 1D) .
Characterization of the Effects of Ca 2ϩ on the IP 3 ReceptorThe effects of extravesicular Ca 2ϩ concentration on IP 3 receptor activity were examined using a standard IP 3 concentration of 10 M, and measuring the net IP 3 -dependent 45 Ca 2ϩ release rates. Increasing the Ca 2ϩ concentrations from nanomolar levels up to 3 M resulted in marked changes in the kinetics of 45 Ca 2ϩ release; the maximal rate of release was greater and occurred more rapidly, and the decay of the fast component of release was accelerated ( Fig. 2A) . However, with increases in Ca 2ϩ concentrations above 3 M, the maximal rate of release and the cumulative release of 45 Ca 2ϩ decreased. Analysis of the relationship between the maximal rate of release or the initial rate of release and the extravesicular Ca 2ϩ concentration was biphasic ( Fig. 2B ) as has been shown for the IP 3 -dependent 45 Ca 2ϩ release in rat brain (3, 5) . Significantly, when we analyzed the relationship between cumulative release and extravesicular Ca 2ϩ concentration, we observed stimulation of release with Ca 2ϩ concentrations less than 1 M, but the concentration-response relationship was shifted to lower Ca 2ϩ concentrations. This observation emphasized the need to make measurements on a subsecond time scale in order to study the aspects of regulation of the transient properties of the IP 3 receptor.
Characterization of the Effects of IP 3 on the IP 3 Receptor-To investigate the potency of IP 3 in this system, the IP 3 concentration of the stimulation buffer was varied while holding the free Ca 2ϩ concentration constant (400 nM). As the IP 3 concentration in the stimulation buffer was increased from 0.3 to 50 M, the maximal rate of release increased and occurred faster (Fig. 3A) . The fast component of calcium release was not detectable at IP 3 concentrations of 300 nM or less, but could be observed as the IP 3 concentration was increased into the micromolar range. The amplitude of the slow component of release was similar at all IP 3 concentrations, but the peak rate was reached more rapidly as the concentration of the agonist was increased. Decay of the fast component increased with the IP 3 concentration, but the decay was not solely dependent on depletion of intravesicular calcium. Because of the increased rate of decay at IP 3 concentrations above 10 M, the intravesicular 45 Ca 2ϩ content at the end of the fast phase was greater than for lower concentrations of IP 3 where decay of release rates was slower.
Inspection of the cumulative IP 3 -dependent 45 Ca 2ϩ release clearly showed sigmoidal kinetics, most demonstrably at lower IP 3 concentrations (Fig. 3B) . Concentration-response relationships were plotted for initial release rates and cumulative release after 2.55 s of stimulation (Fig. 3C) . The initial rate data were fit by non-linear least squares regression, yielding the following parameters; the Hill coefficient (n H ) was 3.4, the V max value was 4.4% per s, and the apparent K m value for IP 3 was 4.5 M. Significantly, analysis of the relationship between IP 3 concentration and the cumulative release measured after 2.55 s of stimulation was best described by a normal hyperbolic fit, i.e. the Hill coefficient of these data is 1.2, V max value was 1.7% per s, and the apparent K m value for IP 3 was 0.9 M. This analysis demonstrates that the sigmoidicity of the concentration-response analysis is best observed when measuring the initial release events.
IP 3 , which could confound attempts to measure receptor inactivation. The vesicles were superfused with basal buffer as usual, and at t ϭ Ϫ1.50 s, the superfusion buffer was switched to a prestimulus solution that contained either 1 nM Ca 2ϩ (q, ࡗ) or 1 nM Ca 2ϩ , 10 M IP 3 (छ) (Fig. 4A) . At t ϭ 0, the solution was again switched to a test buffer containing 400 nM Ca 2ϩ , 10 M IP 3 (ࡗ, छ), or 400 nM Ca 2ϩ only (q). Prestimulation with 10 M IP 3 , 1 nM Ca 2ϩ produced a small amount of 45 Ca 2ϩ release (Fig. 4 , B and C), but not enough to significantly reduce the amount of 45 Ca 2ϩ contained in the vesicles (less than 0.2% of total). However, prestimulation with IP 3 significantly inhibited the response to the test buffer. The initial rate of 45 Ca 2ϩ release was diminished by 42% by prestimulation with 10 M IP 3 . When the peak rate of release observed after prestimulation was scaled to the peak rate of release in the control experiment (ϫ), it was apparent that there was no qualitative change in the rate of decay or the relative amplitudes of the two components, consistent with agonist-dependent inactivation of the IP 3 receptor, leading to a diminished response to the test buffer due to a decrease in the number of receptors available to conduct Ca 2ϩ efflux.
DISCUSSION
The aim of this study was to examine the regulation of the IP 3 receptor by two second messengers implicated in its function, IP 3 and Ca 2ϩ . We used a subsecond kinetic approach to measure 45 Ca 2ϩ release from microsomes prepared from rat liver. IP 3 -dependent 45 Ca 2ϩ release from hepatic microsomes was rapid and transient when strong stimulation was used. The decay of this release event was fit by two exponentials, representing an initial fast phase superimposed on a slower phase of Ca 2ϩ release, as noted previously (9, 15 release. Hepatic microsomes were superfused with basal buffer to establish a baseline release rate. At t ϭ 0, the superfusion buffer was switched to a stimulating buffer that contained 400 nM Ca 2ϩ (q, n ϭ 9) or 400 nM Ca 2ϩ and 10 M IP 3 (å, n ϭ 9). The rate of Ca 2ϩ release reached a maximum within two fractions (ϳ140 ms) and decayed monotonically thereafter. B, inhibition of IP 3 -dependent Ca 2ϩ release by heparin. Superfusion with 10 M IP 3 at 400 nM Ca 2ϩ with (छ, n ϭ 6) or without (ࡗ n ϭ 6) heparin (100 g/ml). C, the net IP 3 -dependent release was calculated by subtracting release measured in the absence of IP 3 from that in its presence (ࡗ). The smooth curve describes the net release fit to the sum of two exponentials: y ϭ A 1 e Ϫk1t ϩ A 2 e Ϫk2t ϩ C, where A 1 ϭ 0.287% s Ϫ1 , A 2 ϭ 0.045% s
Ϫ1
, k 1 ϭ 7.71 k 2 ϭ 1.37 s
, and C ϭ 0.011% s Ϫ1 . D, the cumulative release obtained by summing net IP 3 -dependent release rate as a function of time. Smooth curve is the integral of the fit in C.
The superfusion method used in this study possesses unique advantages. Classical filtration studies rely on the calculation of the IP 3 -dependent calcium release by measuring the 45 Ca 2ϩ remaining in the stores of different experimental samples before and after partial discharge by IP 3 . The superfusion method directly and continuously measures release rates. The high flow rate (2 ml/s) relative to the small volume of the superfusion chamber (ϳ30 l) allows rapid solution changes ( ϭ 40 ms) and precise control of the extravesicular concentrations of IP 3 and calcium. Continuous superfusion of the membranes alleviates possible agonist depletion or degradation. The resulting rapid chelation of released 45 Ca 2ϩ by EDTA isolates the efflux of Ca 2ϩ from its reuptake and minimizes accumulation of Ca 2ϩ near the channel pore which might influence its activity. This contrasts with studies of permeabilized hepatocytes, in which changes in fluorescence of the calcium-sensitive dye Fura 2 were measured. This experimental protocol is limited, due to membrane permeabilization (17) , the inability to isolate Ca 2ϩ release from Ca 2ϩ reuptake, and poor control over changes in IP 3 and Ca 2ϩ concentrations in the vicinity of the IP 3 receptor.
Many cells have multiple mechanisms in place to produce calcium release activity. In addition to the IP 3 receptor, hepatocytes contains a ryanodine receptor (18), which is structurally and functional related to the IP 3 receptor. The ryanodine receptor is thought to be responsible for Ca 2ϩ -induced Ca 2ϩ release from the stores, and can be distinguished from the IP 3 receptor by functional criteria. In addition to the being a ligand-gated receptor, the IP 3 receptor is relatively insensitive to Mg 2ϩ (5, 19) . Any ryanodine receptor activity in this preparation would be blocked by the high Mg 2ϩ concentration (5 mM) used in the superfusion buffers. Superfusion with Ca 2ϩ at high concentrations induced only a minimal Ca 2ϩ release, an observation consistent with low levels of ryanodine receptor activity.
In any case, IP 3 -dependent Ca 2ϩ release was always corrected, using the control experiment performed at the same free Ca 2ϩ concentration in the absence of IP 3 .
The initial rate of calcium release was a steep function of IP 3 concentration. The apparent Hill coefficient of 3.4 suggests that binding of at least 3 IP 3 molecules to the channel is required for activation of the ion channel activity, as suggested previously (8) . Our results differ from those reported by Finch et al. (5) who used the same assay with synaptosomes-derived microsomal vesicles. Their experiments were performed at 10 M Ca 2ϩ , which could explain a loss in apparent cooperativity. Combettes (20) , using permeabilized hepatocytes, reported significantly reduced apparent cooperativity at a Ca 2ϩ concentration of 10 M compared to 100 nM. In contrast, the relationship between IP 3 concentration and cumulative Ca 2ϩ release (after 2.55 s of stimulation) had a Hill coefficient of ϳ1.2. The apparent potency of IP 3 , when based on cumulative release (0.9 M), was somewhat higher than that based on the initial rate of release (4.5 M). Using a stopped-flow method with permeabilized hepatocytes, Champeil et al. (9) determined comparable apparent affinities (0.2 and 1 M respectively). At 10 M free Ca 2ϩ concentration, i.e. at saturating concentrations of Ca 2ϩ required for the coagonist effect, Finch et al. (5) found that the initial release rate and the cumulative release had the same dependence on IP 3 concentration, suggesting that IP 3 -dependent Ca 2ϩ release was transient even at low IP 3 concentrations. Combettes (19) reported that, at low concentrations of both Ca 2ϩ and IP 3 , the release event is sustained, which is consistent with our data. This was subsequently confirmed by Finch (21) ; at 10 and 300 nM free Ca 2ϩ concentrations, well below the range of extravesicular Ca 2ϩ concentrations that inhibit release, the apparent potency of IP 3 was higher when cumulative measurements of Ca 2ϩ release over 2 s were used rather than the maximum rate of 45 Ca 2ϩ release. IP 3 -dependent inactivation of IP 3 receptor has been reported previously (11) . In these experiments, the Ca 2ϩ channel of the IP 3 receptor function was assessed by measuring the quench of Fura 2 fluorescence by Mn 2ϩ entry into the stores. This approach assumes that Mn 2ϩ moves inward through the IP 3 receptor from the cytoplasm of permeabilized hepatocytes into empty Ca 2ϩ stores, and mimics the flux of Ca 2ϩ through the Ca 2ϩ channel. Our design allows preincubation with IP 3 without significant movement of Ca 2ϩ and measures directly Ca release has been described in Xenopus oocytes (3), smooth muscle (4), brain (5, 6) , and hepatocytes (7). This property is important to our understanding of the mechanisms of Ca 2ϩ waves (2, 22, 23) , but has been recently suggested to be an effect produced by the metal-free Ca 2ϩ chelators used to buffer calcium (19, 24 3 . A, microsomes were pretreated with 1 nM Ca 2ϩ with (छ) or without (q, ࡗ) 10 M IP 3 for 1.5 s prior to the test pulse. At t ϭ 0, a test pulse containing 400 nM Ca 2ϩ with (छ, ࡗ) or without (q) 10 M IP 3 was delivered. Results are the mean of two experiments performed in duplicate. B, net difference between the baseline run (1 nM Ca 2ϩ followed by 400 nM Ca 2ϩ test pulse) and the two IP 3 runs shows the inhibition produced by prestimulation with 10 M IP 3 (छ). The peak rate of release in the prestimulation run was scaled to the peak rate in the control run (ϫ), demonstrating that pre-exposure to IP 3 inhibited the amplitude of the response to the test pulse, did not significantly alter the kinetics of decay or the relative contributions of the fast and slow components.
doses (20) . We exposed hepatic microsomes to IP 3 (10 M) and the desired free Ca 2ϩ concentration using EDTA as a calcium buffer. We found that when measured on a subsecond time scale, cytosolic Ca 2ϩ at submicromolar concentration activated the initial rate of IP 3 -dependent 45 Ca 2ϩ release, consistent with the role of Ca 2ϩ as a coagonist of the IP 3 receptor. Our results do not exclude the possibility that metal-free chelators are inhibitors of the IP 3 receptor, but they confirm that at submaximal IP 3 concentration, Ca 2ϩ activates IP 3 -dependent calcium release during the first 100 -200 ms of stimulation.
The transient nature of the IP 3 -dependent calcium release observed in these experiments is potentially an important property of the IP 3 receptor. Repetitive oscillatory calcium signals that diffuse as kinematic waves can only occur if mechanisms exist to terminate calcium release. Many cellular mechanisms exist which could explain the transient nature of the IP 3 induced calcium release from hepatic microsomes. For example, sequential increases and decreases in IP 3 concentration, local transients of Ca 2ϩ concentration near the mouth of the pore, or depletion of intravesicular Ca 2ϩ all could lead to transient release patterns. These possibilities seem unlikely in our system, since agonist concentrations were held constant during the experiment, and the vesicles were superfused at high flow rates with a strong Ca 2ϩ buffer to clamp the extravesicular Ca 2ϩ concentration. As for depletion, the vesicles were always loaded to the same extent, and therefore to the same initial intravesicular Ca 2ϩ concentration. At higher IP 3 concentrations, the fast phase of release decayed more rapidly, resulting in higher luminal Ca 2ϩ content at the end of the release event (Fig. 3b) , arguing that the decay is not solely due to depletion of intravesicular Ca 2ϩ . The simplest model to account for our observations incorporates IP 3 -dependent as well as calcium-dependent inactivation of the receptor. By mass action, increases in IP 3 concentrations lead to an increase in the fraction of receptors in the fully liganded conformation (Fig. 5) . By analogy with cell surface ionotropic receptors such as the nicotinic acetylycholine receptor (25) and N-methyl-D-aspartate receptors (26) , this conformation is in equilibrium with two states, the open state that conducts calcium, and an inactive conformation that does not. As the calcium concentration is increased into the micromolar range, the equilibrium between fully-liganded receptor and the FIG. 5 . Numerical simulation of IP 3 receptor kinetics. The kinetic behavior of the IP 3 receptor was simulated using a numerical method (27) . The model assumed that the receptor consists of a tetramer, and that each monomer must be occupied by ligand (IP 3 ) for the channel to be activated. The fully-occupied receptor exists in equilibrium with two distinct states, the activated state (R 4 * ) that conducts ion flux, and an absorbing inactivated state (R 4x ) that does not conduct ion flux. active ion channel is shifted to favor the activated state, allowing for calcium efflux. At nanomolar calcium concentrations, the fully liganded receptor enters the inactive conformation without going through the active state. Thus, at low calcium concentrations, application of IP 3 leads to a significant fraction of receptors that are occupied by IP 3 , but the open state of the receptor is bypassed, resulting in accumulation of the receptor in the inactivated state. Numerical simulations (27) In conclusion, we have conducted experiments designed to obtain quantitative data regarding the regulation of the IP 3 receptor by the two second messengers, Ca 2ϩ and IP 3 . We have provided substantive evidence that both IP 3 and Ca 2ϩ alter the calcium channel activity of the receptor in a similar fashion, such that either ligand promotes receptor inactivation, but both coagonists are required to maximize calcium release activity. The coincidence properties of the IP 3 receptor are likely to have profound implications in the maintenance of intracellular calcium waves, and in regulation of cellular activity.
